Summer 2012

Inhibiting Hedgehog signaling pathway may improve pancreatic cancer treatment

Combining a new targeted therapy with standard chemotherapy may help defeat pancreatic cancer, according to recent findings by University of Michigan Comprehensive Cancer Center researchers. The results were presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, which was held in Lake Tahoe, Nevada, in June.